1. Academic Validation
  2. hKSR-2 inhibits MEKK3-activated MAP kinase and NF-kappaB pathways in inflammation

hKSR-2 inhibits MEKK3-activated MAP kinase and NF-kappaB pathways in inflammation

  • Biochem Biophys Res Commun. 2005 Sep 9;334(4):1214-8. doi: 10.1016/j.bbrc.2005.07.009.
Padma L Channavajhala 1 Vikram R Rao Vikki Spaulding Lih-Ling Lin Y George Zhang
Affiliations

Affiliation

  • 1 Department of Inflammation, Wyeth Research, Cambridge, MA 02140, USA.
Abstract

Kinase suppressor of Ras (KSR) and MEKK3 (MAP kinase kinase kinase) are integral members of the MAP kinase pathway. We have recently identified a new isoform of the KSR family named human kinase suppressor of ras-2 (hKSR-2), and demonstrated that hKSR-2 negatively regulates Cot, a MAP3K family member which is important in inflammation and oncogenesis [P.L. Channavajhala, L. Wu, J.W. Cuozzo, J.P. Hall, W. Liu, L.L. Lin, Y. Zhang, J. Biol. Chem. 278 (2003) 47089-47097]. In this report, we provide evidence that hKSR-2 also regulates the activity of MEKK3 (another MAP3K family member) in HEK-293T cells. We demonstrate that hKSR-2 is a negative regulator of MEKK3-mediated activation of MAP kinase (specifically ERK and JNK) and NF-kappaB pathways, and concurrently inhibits MEKK3-mediated interleukin-8 production. We find that while hKSR-2 blocks MEKK3 activation, it has little to no effect on other members of the MAP3K family, including MEKK4, TAK1, and Ras-Raf, suggesting that its effects are selective.

Figures